Roche reportedly warns Trump’s executive order can risk its U.S. investments

1 month ago 5
Roche Diagnostics campus facade in Silicon Valley

Michael Vi/iStock Editorial via Getty Images

Swiss pharma giant Roche (OTCQX:RHHBY) has warned that President Donald Trump’s latest executive order to drastically cut prescription drug prices will harm its ability to fund its recently announced U.S. investments, according to multiple media reports on Wednesday.

Trump signed

Recommended For You

More Trending News

Read Entire Article